P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury

American Journal of Transplantation

Volumn 2, Issue 7, 2002, Pages 600-608

  Amersi, Farin ^a   Farmer, Douglas G ^a   Shaw, Gray D ^c   Kato, Hirohisa ^a   Coito, Ana J ^a   Kaldas, Fady ^a   Zhao, Delai ^a   Lassman, Charles R ^b   Melinek, Judy ^b   Ma, Jeffrey ^a   Volk, Hans Dieter ^d   Kupiec Weglinski, Jerzy W ^a   Busuttil, Ronald W ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PFIZER INC   (United States)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Hepatic steatosis, PSGL 1; Reperfusion injury, selectin

Indexed keywords

GLYCOPROTEIN; LIGAND; PADGEM PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FATTY LIVER; KUPFFER CELL; LIVER FUNCTION; LIVER GRAFT; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; MEDIATOR RELEASE; MICROCIRCULATION; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STEATOSIS;

ANIMALS; CYTOKINES; GRAFT SURVIVAL; LIVER; LIVER TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; ORGAN PRESERVATION; P-SELECTIN; PEROXIDASE; RATS; RATS, ZUCKER; REPERFUSION INJURY; STEATITIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036705298     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20704.x     Document Type: Article

References (52)

1. D'Allessandro AM, Kalayoglu M, Sollinger HM. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51: 157-163.
2. Markin RS, Wisecarwer JL, Radio SJ et al. Frozen section evaluation of donor livers before transplantation. Transplantation 1993; 56: 1403-1409.
3. Underwood KE. Prevalence of fatty liver in healthy male adult accidentally killed. Aviat Space Environ Med 1984; 55: 59-63.
4. Hilden M, Christoffersen P, Juhl E, Dalggard J. Liver histology in a normal population - examination of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977; 12: 593-597.
5. Ploeg RJ, D'Aleessandro AM, Knechtle SJ et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993; 55: 807-813.
6. Todo S, Demetris AJ, Makowka L et al. Primary non-function of hepatic allografts with pre-existing fatty infiltration. Transplantation 1989; 47: 903-905.
7. Lemasters JJ, Bunzendahl H, Thurman RG. Reperfusion injury to donor livers stored for transplantation. Liver Transplant Surg 1995; 1: 124-138.
8. Farmer DG, Amersi F, Kupiec-Weglinski JW, Busuttil RW. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 2000; 14: 106-126.
9. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991; 13: 83-95.
10. Trevisani F, Colantoni A, Caraceni P, Van Thiel DH. The use of fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol 1996; 24: 114-121.
11. Selzner M, Rudiger HA, Sindram D, Madden J, Claven PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32: 1280-1288.
12. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
13. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355-3359.
14. Suzuki S, Toledo-Pererya LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265-1272.
15. McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 1995; 270: 11025-11028.
16. Sako D, Chang XJ, Barone KM et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75: 1179-1186.
17. Moore KL, Stults NL, Diaz S et al. Identification of a specific glycoprotein ligand for P-selectin (CD 62) on myeloid cells. J Cell Biol 1992; 118: 445-456.
18. Norman KE, Moore KL, McEver RP, Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand 1. Blood 1995; 86: 4417-4421.
19. Moore KL, Patel KD, Breuhl RE et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995; 128: 661-671.
20. Yang J, Hirata T, Croce K et al. Targeted gene disruption demonstrates that p-selectin glycoprotein ligand (PSGL-1) is required for p-selectinmediated but not e-selectin-mediated neutrophil rolling and migration. J Exp Med 1999; 190: 1769-1782.
21. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney - inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682-2690.
22. Takada M, Nadeau KC, Shaw GD et al. Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation 1997; 64: 1520-1525.
23. Dulkanchainun T, Goss JA, Imagawa DK et al. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg 1998; 227: 832-840.
24. Sako D, Chang XJ, Barone KM et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75: 1179-1186.
25. Sako D, Comess KM, Barone KM, Camphausen RT, Cumming DA, Shaw GD. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 1993; 83: 323-328.
26. Kumar A, Villani MP, Patel UL, Keith JC, Schaub R. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 1999; 99: 1363-1369.
27. Morgan A, Jones ND, Nesbitt AM, Chaplin L, Bodmer MW, Emtage JS. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gammaR1 and Fc gamma RIII binding. Immunology 1995; 86: 319-324.
28. Khor SP, McCarthy K, DuPont M, Murray K, Timony G. Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase I trial. J Phamacol Exp Ther 2000; 293: 618-624.
29. Kumar R, Camphausen RT, Sullivan FX, Cummings DA. Core2 β-1,6N-acetylglucosaminyltransferase enzyme activity is critical for PSGL-1 binding to P-selectin. Blood 1996; 88: 3872-3879.
30. Takada M, Nadeau KC, Hancock WW et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65: 1533-1542.
31. Kamada N, Calne RY. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47-50.
32. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14: 157-167.
33. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 1993; 55: 1265-1272.
34. Coito AJ, Binder J, de Sousa M, Kupiec-Weglinski JW. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats. Transplantation 1994; 57: 599-605.
35. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-994.
36. Kim YI, Akizuki S, Kawano K, Goto S. Intrahepatic neutrophil accumulation in ischemia/reperfusion injury of pig liver. Transplant Proc 1994; 26: 2392-2394.
37. Thurman RG, Marzi I, Seitz G, Thies J, Lemasters JJ, Zimmerman F. Hepatic reperfusion injury following orthotopic liver transplantation in the rat. Transplantation 1988; 46: 502-506.
38. Bertozzi CR. Cracking the carbohydrate code for selectin recognition. Chem Biol 1995; 2: 703-708.
39. Olofsson AM, Arfors KE, Ramezani L, Wolitzky BA, Butcher EC, von Andrian UH. E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules. Blood 1994; 84: 2749-2758.
40. Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice: Eselectin is required for slow leukocyte rolling in vivo. Circ Res 1996; 79: 1196-1204.
41. Moore KL, Eaton SF, Lyons DE. The P-selectin glycoprotein ligand from human neutrophils displays sialytated, fucosylated, O-linked poly-Nacetyl-lactosamine. J Biol Chem 1994; 269: 23318-23327.
42. Wilkins PP, McEver RP, Cummings RD. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL60 cells. J Biol Chem 1996; 271: 18732-18741.
43. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton D. GMP-140, a platelet alpha-granule membrane protein, is also syn-thesized by vascular endothelial cells and is localized in the Weibel-Palade bodies. J Clin Invest 1989; 84: 92-99.
44. Borges E, Eytner R, Moll R et al. The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood 1997; 90: 1934-1942.
45. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993; 91: 2620-2629.
46. Mulligan MS, Polley MJ, Bayer RJ, Nunn MF, Paulson JC, Ward PA. Neutrophil dependent acute lung injury: requirement for P-selectin (GMP-140). J Clin Invest 1992; 90: 1600-1607.
47. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999; 29: 1494-1502.
48. Scalia RR, Hayward V, Armstead VE, Minchenko AG, Lefer AM. Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyteendothelium interaction in vivo: role in traumatic shock. Circ Res 1999; 84: 93-102.
49. Kusaka M, Zandi-Nejad K, Kato S et al. Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness. Transplantation 1999; 67: 1255-1261.
50. Norman KE, Katopodis AG, Thoma G et al. P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo. Blood 2000; 96: 3585-3591.
51. Yang J, Hirata T, Croce K et al. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand-1 (PSGL-1) is required for P-selectin but not E-selectin-mediated neutrophil rolling and migration. J Exp Med 1999; 190: 1769-1782.
52. Zhai Y, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW. Th1 and Th2 cytokines in organ transplantation: paradigm lost? Crit Rev Immunol 1999; 19: 155-172.